About Blackrock Health Sciences Trust (NYSE:BME)
BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.
Industry, Sector and Symbol
Industry Closed-End Fund - Equity
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Blackrock Health Sciences Trust (NYSE:BME) Frequently Asked Questions
What is Blackrock Health Sciences Trust's stock symbol?
Blackrock Health Sciences Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BME."
How often does Blackrock Health Sciences Trust pay dividends? What is the dividend yield for Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust announced a monthly dividend on Tuesday, April 3rd. Investors of record on Monday, April 16th will be paid a dividend of $0.20 per share on Monday, April 30th. This represents a $2.40 annualized dividend and a dividend yield of 6.87%. The ex-dividend date of this dividend is Friday, April 13th. View Blackrock Health Sciences Trust's Dividend History.
Who are some of Blackrock Health Sciences Trust's key competitors?
Some companies that are related to Blackrock Health Sciences Trust include Heritage Commerce (HTBK), Investors Real Estate Trust (IRET), Peapack-Gladstone Financial (PGC), Bridge Bancorp (BDGE), Fidelity Southern (LION), Armada Hoffler Properties (AHH), Yintech Investment (YIN), QCR (QCRH), First Defiance Financial (FDEF), Oaktree Specialty Lending (OCSL), Access National (ANCX), People's Utah Bancorp (PUB), Bancorp (TBBK), Merchants Bancorp (MBIN), Maiden (MHLD), Equity BancShares (EQBK), FRP (FRPH) and Mercantile Bank (MBWM).
Who are Blackrock Health Sciences Trust's key executives?
Blackrock Health Sciences Trust's management team includes the folowing people:
- Mr. John M. Perlowski CPA, Chief Exec. Officer and Pres
- Mr. Neal J. Andrews, Chief Financial Officer
- Mr. Choon Sik Park, Chief Compliance Officer and Anti-Money Laundering Officer
- Mr. Michael D. Carey CFA, Managing Director and Portfolio Mang.
- Mr. Jay M. Fife, Treasurer
Has Blackrock Health Sciences Trust been receiving favorable news coverage?
News headlines about BME stock have been trending somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Blackrock Health Sciences Trust earned a coverage optimism score of 0.03 on Accern's scale. They also gave media coverage about the company an impact score of 45.42 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.
How do I buy shares of Blackrock Health Sciences Trust?
Shares of BME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Blackrock Health Sciences Trust's stock price today?
One share of BME stock can currently be purchased for approximately $34.91.
How big of a company is Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust has a market capitalization of $328.67 million.
How can I contact Blackrock Health Sciences Trust?
Blackrock Health Sciences Trust's mailing address is 100 Bellevue Pkwy, WILMINGTON, DE 19809-3700, United States. The company can be reached via phone at +1-800-8820052.
MarketBeat Community Rating for Blackrock Health Sciences Trust (BME)MarketBeat's community ratings are surveys of what our community members think about Blackrock Health Sciences Trust and other stocks. Vote "Outperform" if you believe BME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BME will underperform the S&P 500 over the long term. You may vote once every thirty days.
Blackrock Health Sciences Trust (NYSE:BME) Analyst Ratings History
(Data available from 4/19/2016 forward)
|Date||Brokerage||Action||Rating||Price Target||Impact on Share Price||Details|
Blackrock Health Sciences Trust (NYSE:BME) Dividend Information
Blackrock Health Sciences Trust pays an annual dividend of $2.40 per share, with a dividend yield of 6.87%. BME's next monthly dividend payment will be made on Monday, April 30.
|Dividend Growth:||10.10% (3 Year Average)|
Blackrock Health Sciences Trust (NYSE:BME) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Blackrock Health Sciences Trust (NYSE BME) Insider Trading and Institutional Ownership History
Blackrock Health Sciences Trust (NYSE BME) Insider Trading History
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/15/2017||Gary Gordon Cope||Director||Sell||700,000||$0.57||$399,000.00|
|6/6/2017||Gary Gordon Cope||Director||Buy||8,500||$0.64||$5,440.00|
|6/5/2017||Gary Gordon Cope||Director||Buy||11,500||$0.66||$7,590.00|
|5/15/2017||Gary Gordon Cope||Director||Buy||9,000||$0.90||$8,100.00|
|5/2/2017||Gary Gordon Cope||Director||Buy||2,000||$0.98||$1,960.00|
|2/9/2017||Gary Gordon Cope||Director||Buy||400||$1.40||$560.00|
|2/2/2017||Gary Gordon Cope||Director||Sell||200,000||$1.45||$290,000.00|
|11/7/2016||Gary Gordon Cope||Director||Buy||10,000||$0.90||$9,000.00|
|3/28/2016||Gary Gordon Cope||Director||Buy||24,500||$0.17||$4,165.00|
|3/25/2016||Gary Gordon Cope||Director||Buy||1,000||$0.17||$170.00|
|3/24/2016||Gary Gordon Cope||Director||Buy||1,000||$0.17||$170.00|
|3/23/2016||Gary Gordon Cope||Director||Buy||80,500||$0.17||$13,685.00|
|3/22/2016||Gary Gordon Cope||Director||Buy||24,000||$0.17||$4,080.00|
|1/27/2016||Gary Gordon Cope||Director||Buy||3,000||$0.08||$240.00|
|1/26/2016||Gary Gordon Cope||Director||Buy||44,000||$0.0850||$3,740.00|
|1/25/2016||Gary Gordon Cope||Director||Buy||6,000||$0.0850||$510.00|
|1/14/2016||Gary Gordon Cope||Director||Buy||54,500||$0.10||$5,450.00|
|11/19/2015||Gary Gordon Cope||Director||Buy||5,000||$0.1350||$675.00|
|10/28/2015||Gary Gordon Cope||Director||Buy||1,500||$0.10||$150.00|
|10/27/2015||Gary Gordon Cope||Director||Buy||3,000||$0.13||$390.00|
|10/1/2015||Gary Gordon Cope||Director||Buy||15,000||$0.10||$1,500.00|
Blackrock Health Sciences Trust (NYSE BME) News Headlines
Blackrock Health Sciences Trust (NYSE:BME) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Blackrock Health Sciences Trust (NYSE BME) Stock Chart for Thursday, April, 19, 2018